Chapter 49: Problem 5
What is the difference between biomarker and risk marker?
Short Answer
Step by step solution
Key Concepts
These are the key concepts you need to understand to accurately answer the question.
/*! This file is auto-generated */ .wp-block-button__link{color:#fff;background-color:#32373c;border-radius:9999px;box-shadow:none;text-decoration:none;padding:calc(.667em + 2px) calc(1.333em + 2px);font-size:1.125em}.wp-block-file__button{background:#32373c;color:#fff;text-decoration:none}
Learning Materials
Features
Discover
Chapter 49: Problem 5
What is the difference between biomarker and risk marker?
These are the key concepts you need to understand to accurately answer the question.
All the tools & learning materials you need for study success - in one app.
Get started for free
Top-down approach in studies of systems biology is preferential over bottom-up approach because: a. it provides more global view b. it allows for faster conclusions which will lead to direct development of clinical tests c. requires less sophisticated technology and instrumentation d. both approaches are equal
How does studying the proteome compare to studying the genome?
Explain in which cases SELDI-TOF technology will be more advantageous than LC- MS/MS and/or MALDI-TOF.
Successful translation of results from laboratory to clinic depends on: a. exploratory research studies b. validation c. prospective screening studies on large-scale population d. all of the above
While planning proteomics experiments, a researcher should: a. have available all types of mass spectrometers b. mandatory access to protein microarrays c. be aware of strength and weaknesses of each technology d. always be an expert in statistics and computer programming for solving problems associated with bioinformatics
What do you think about this solution?
We value your feedback to improve our textbook solutions.